Retinalamin

Product Details: Retinalamin

Retinalamin is a peptide-based research compound derived from retinal tissue extracts and is currently utilized in laboratory settings for experimental purposes. It is composed of a complex of low-molecular-weight polypeptide fractions that are being studied for their potential role in cellular signaling and tissue-specific activity in preclinical models.

In experimental environments, Retinalamin is being investigated for its interaction with cellular pathways associated with retinal structures in research models. Early-stage studies suggest that this compound may influence cellular processes such as protein synthesis and metabolic regulation in specialized tissues under controlled laboratory conditions.

Mechanism of Action

Following administration in controlled laboratory models, Retinalamin is believed to break down into smaller peptide fractions. These fragments may interact with intracellular signaling pathways and influence gene expression patterns associated with cellular maintenance and regulation in experimental systems.

Preliminary investigations indicate that these peptide fractions may contribute to the regulation of metabolic activity and protein synthesis in targeted tissues. Additionally, Retinalamin is being explored for its potential to support cellular communication pathways and maintain structural integrity in laboratory-based studies.

Properties of Retinalamin: 

• Molecular Formula: Not fully characterized (peptide complex)

• Molecular Weight: Variable (low-molecular-weight polypeptides)

• CAS Number: Not assigned

• PubChem CID: Not assigned

Research Applications/Benefits of Retinalamin

Retinal Cell Regeneration & Repair:

In preclinical models, Retinalamin has been studied for its potential to stimulate photoreceptor cells and associated retinal structures. It may enhance interactions between retinal pigment epithelium (RPE) and the outer segments of photoreceptors and support protein synthesis, which is essential for cellular repair processes under controlled laboratory conditions.

Neuroprotective Effects:

Retinalamin is investigated in experimental retinal systems for its ability to protect retinal neurons from damage induced by stressors such as excitotoxicity. Early laboratory findings indicate it may reduce neuronal cell degeneration in models designed to simulate retinal damage or dysfunction.

Improved Microcirculation:

Experimental studies suggest Retinalamin may positively influence microcirculatory parameters in retinal tissue models, supporting the distribution of oxygen and nutrients within preclinical setups.

Anti-Inflammatory and Antioxidant Properties:

In laboratory settings, Retinalamin is examined for its potential to modulate inflammatory responses and oxidative stress in retinal cells. These investigations focus on understanding cellular resilience mechanisms in controlled research models.

Functional Parameters in Retinal Models:

In vitro and ex vivo retinal experiments have used Retinalamin to study its possible effects on functional activity within photoreceptor and RPE systems. Observations are limited to experimental setups and aim to understand cellular signaling and responsiveness under research conditions.

Why Choose BehemothLabz to Buy Retinalamin

BehemothLabz specializes in supplying high-purity research compounds designed for controlled laboratory applications. Our Retinalamin is produced under stringent quality control measures to ensure consistency, stability, and reproducibility in experimental models.

Each lot is independently analyzed by third-party laboratories to confirm composition and purity, supporting reliable outcomes in preclinical studies and laboratory investigations.

We offer secure ordering and carefully managed shipping, both domestically and internationally, with protocols in place to protect confidentiality and safeguard sensitive research materials.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments. 

References: 

1. Suetov, A., Alekperov, S., Odinokaya, M., & Kostina, A. (2021). Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas. Russian Annals of Ophthalmology, 137(5), 57. https://doi.org/10.17116/oftalma202113705157
2. Neroev, V. V., Zaitseva, O. V., Okhotsimskaya, T. D., Tsapenko, I. V., & Lantukh, E. P. (2018). The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration. Russian Ophthalmological Journal, 9(1), 39–46. https://doi.org/10.21516/2072-0076-2016-9-1-39-46